Navigation Links
Zenotech Issues 20 Lakh Shares to Ranbaxy for Rs 20 Cr

Zenotech Laboratories Ltd today said it will issue 20 lakh equity shares to Ranbaxy Laboratories on a preferential basis for Rs 20 crore. //

The board of directors has approved the issue of 20 lakh equity shares of Rs 10 at a price of Rs 100 on a preferential basis to Ranbaxy, subject to shareholders' approval, the company informed the Bombay Stock Exchange.

The board also approved the allotment of shares over 1.11 crore equity shares to the erstwhile shareholders of Credence Pharmaceuticals (50.07 lakh shares) and Hemarus Healthcare (61. 20 lakh equity shares) pursuant to the Scheme of amalgamation entered between Credence and Hemarus Healthcare with the company, it said.

The scheme had been approved by the High Court of Andhra Pradesh at Hyderabad in its order dated May 02, 2006, it added.

The Extra Ordinary General Meeting will be held on August 10 to seek the shareholder's approval for the above proposal.

Zenotech's shares closed at Rs 72, up 1.69 per cent at the BSE.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Ranbaxy Signs Agreement With Zenotech For Cancer Drugs
2. Unsatisfactory Grade On Womens Health Issues
3. Who Board To Discuss Asian Tsunami Related Health Issues
4. WHO Issues Caution Against Bird Flu Epidemic
5. FDA Issues Public Health Advisory on Tysabri, a New Drug for MS
6. Sepsis Death Reported With Mifepristone – FDA Issues Warnin
7. High Court Issues Notice To Centre On Smoking Ban In Films
8. JRRD Focuses On Issues Such As Spinal Cord Injury and Prosthetics
9. China Issues New Legislation To Ban Human Organ Trade
10. Court Issues Order NACO On Gay Issue
11. NGOs and Various Groups Come Together To Address the Issues on AIDS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, ... dedicated to helping service members that have been wounded in battle and their families. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: